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  UrQIQgical operations are oftβn perfor皿ed for diseases associated with urinary infection Or
are frequently followed by postoperative infection． This is the reason we need a potent an－
tibiotic just like hetacillin， a newly synthesized ’broad spectrum penici！lln． The clinical ev・a－
luation of hetacillin （cernmercially Ni ataci／lin） was made on the postoperative infection or on
the cases with indwelling catheter．
  Postoperative infusion of the massive dosis of hetacillin resulted in iniprovement oi iiifec－
tion recognized preol］eratively and prevention of new infection due to indwell，lng catheter．
  Various fuDction tests prove〔i on harnユfuユeffect． on ally vitaユ organ． Fronユthe above re－
sults， it was concluded that the ／arge dosis intravenous administration of hetacillin in the
early・ postoperative period is quite va． luable．















































































































































































腎  結  石
膀胱頸部硬化症
尿道直腸疲
陰 茎  癌
腎  結  石
尿道狭窄
前立腺肥大症
腎  結  石
膿  腎  症
前立腺肥大症
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かかってくる． Boen， J． R． et a1．（1969），



























         質を初期に大量点滴静注する方法がはなはだ効
         果的であるとの治験を得た．
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         L一アラニン  100mg
         日局’アミノ酢酸  45mg
 《適応症》
  前立腺肥大に伴う排尿障害、残尿および残尿
 感、頻尿。
 《用法・用量》
  通常1回2カプセル、1日3回経口投与する．
  なお、症状により適宜増減する。
《包装》  100cap．500cap．1，000cap．
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